Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2016.
The typical case for the fund is to invest in rounds with 8 participants. Despite the Brohuvudet, startups are often financed by SLS Venture, HealthCap, Q-Med. The meaningful sponsors for the fund in investment in the same round are Ysios Capital, Sunstone Life Science Ventures, Life Sciences Partners.
Among the most successful fund investment fields, there are Health Care, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight OxThera. Moreover, a startup needs to be at the age of 11-15 years to get the investment from the fund.
Related Funds
| Fund Name | Location |
| 1UP | - |
| Bengo 4.com | Chiba Prefecture, Japan, Tateyama |
| China Ministry of Finance | Beijing, Beijing, China |
| Deya Venture Capital | China, Shanxi, Xizhang |
| East River Capital | New York, New York, United States |
| Fringe81 Co.,Ltd | Japan, Tokyo |
| Groupe Revue Fiduciaire | - |
| Hakuhodo | Chiba, Japan, Minato |
| HighSage Ventures | Boston, Massachusetts, United States |
| I-Next Ventures | Luxembourg, Luxembourg |
| Legendary Ventures | New York, New York, United States |
| MedStar Health | Columbia, Maryland, United States |
| Minamidsuka Industry | - |
| Residence Ventures | New York, New York, United States |
| Telkomsel Mitra Inovasi | Indonesia, Jakarta, Jakarta Raya |
| The Grover Trust | - |
| Vista Credit Partners | - |
| Yinling Capital | China, Shanghai |
| Zhitengda | Bao'an District, China, Guangdong Province |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 